HLHanna Lu

Hanna Lu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hanna Lu has a total of 211 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Personalized assessment of high-definition slow-oscillatory transcranial direct current stimulation (so-tDCS) in older adults with sleep and subjective cognitive complaints: A study protocol for a randomized clinical trial

    by Hanna Lu, Xi Ni, Natalie Shu Yang, Yuk Shan Yuen, Yuqi Gong, Suk Ling Ma

    Background: Subjective cognitive decline (SCD) is increasingly recognized as an early and potentially modifiable stage in the trajectory of neurodegenerative diseases. In older adults with SCD, untreated sleep disturbances may accelerate the neurodegenerative process, potentially via mechanisms involving amyloid-beta accumulation, and contribute to more rapid cognitive deterioration. Currently, non-pharmacological treatment options that concurrently manage SCD and sleep disturbances remain scarce. High-definition slow-oscillatory transcranial direct current stimulation (so-tDCS) is an emerging, frequency-specific neuromodulation technique designed to enhance brain health and cognition. Methods and design: This is a randomized, double-blind, sham-controlled clinical trial. Right-handed Chinese older adults with SCD and sleep disturbances will be randomly assigned to receive either high-definition 0.75 Hz so-tDCS or sham stimulation over a 4-week intervention period, with 40 participants per group. Outcome measures, including galvanic skin response, subjective cognitive complaints, sleep quality, salivary amyloid-beta levels, and domain-specific cognitive performance, will be evaluated at four time points: baseline, week 4 (immediately post‑intervention), and follow‑up at weeks 8 and 12. Conclusions: Personalized neurophysiological signals, namely electrode-skin impedance, will be monitored using state-of-the-art measurement during so-tDCS. The successful implement of this signal will provide researchers with access to an “add-on” setting that enables them to easily, quickly and quantitatively evaluate real-time neurophysiological signals, thereby facilitating the incorporation of transcranial brain stimulation into clinical practice. Trial registration: ClinicalTrials.gov Identifier: NCT07433738

  • Open Access

    Treatment response prediction in major neurocognitive disorder with depression using the scalp-to-cortex distance of TMS targets: implications for personalized dose estimation

    by Hanna Lu, Sandra Sau Man Chan, Suk Ling Ma, Arthur Dun-Ping Mak, Lin Shi, Li Zhang, Linda Chiu Wa Lam

    Neuronavigated repetitive transcranial magnetic stimulation (rTMS) has shown encouraging efficacy in treating various brain disorders. However, substantial inter-individual heterogeneity in treatment response remains a major challenge. In this secondary analysis of a randomized clinical trial, we examined the predictive performance of transcranial features in relation to output measures and responses to rTMS treatment. Fifty-five elderly patients with depression and cognitive impairments were randomly assigned to receive a 3-week treatment of either 10 Hz active rTMS or sham rTMS. Left dorsolateral prefrontal cortex (DLPFC) and primary motor cortex (M1) were the predefined treatment targets. Scalp-to-cortex distance (SCD) was measured as the Euclidean distance between the scalp stimulation site and the corresponding cortical target. SCD-modified output difference (SCD-MOOD) was developed for quantifying the differences between the actual output and target-specific SCD-adjusted output. Responders to rTMS exhibited a greater SCD of left M1, a lower SCD DLPFC/M1 ratio and a higher SCD-MOOD than nonresponders. Logistic regression analyses revealed that clinical remission to active rTMS was significantly associated with SCD of left M1 ( p = 0.038) and SCD-MOOD ( p = 0.042). Moreover, using SCD metrics as predictive features, the responder-nonresponder classification model achieved an accuracy of 92.5% at week 3 and 86.2% at week 12. Pre-treatment SCD metrics of the stimulation targets can effectively predict early rTMS treatment responses. Predictive models integrating with MRI-derived SCD and SCD-MOOD showed strong specificity for active rTMS compared to sham stimulation. This approach may enable the development of effective, personalized protocols to improve region-specific TMS treatment outcomes in clinical practice. Trial registration: ChiCTR-IOR-16008191, registered on March 30, 2016. ClinicalTrials.gov Identifier: NCT05967390

  • Open Access

    Identifying neurophenotypes of major depressive disorder through normative model of regional homogeneity

    by Zhanjie Luo, Weicheng Li, Yubing Xu, Junhao Shen, Chengyu Wang, Xiaofeng Lan, Guanxi Liu, Zhanhui Luo, Zhaoyi Hou, Siming Mai, et al.

    Major depressive disorder (MDD) is a highly heterogeneous mental illness, marked by clinical variability and distinct neuropathological mechanisms. This study sought to enhance diagnostic precision for MDD by identifying neurophenotypes using a normative model of regional homogeneity (ReHo), offering new avenues for precision medicine. Using resting-state functional magnetic resonance imaging data from 1101 patients with MDD and 1011 healthy controls (HCs) sourced from the REST-meta-MDD project, we developed the first normative model of ReHo. Gaussian process regression was applied to predict a normative lifespan trajectory based on age and sex in HCs, enabling quantification of individual deviations from the model for patients with MDD. Unsupervised clustering algorithms were then employed to classify MDD subtypes, followed by validation analyses to assess clustering stability. Significant deviations from the normative ReHo model were observed in patients with MDD. Two distinct MDD subtypes emerged: Emotional dysregulation subtype, characterized by negative deviations in the frontoparietal control network, ventral attention network, default mode network, and limbic network (Cohen’s d = 0.40−1.75, FDR-corrected p < 0.05). This subtype correlated with more severe overall depressive symptom ( d = 0.17, p = 0.010), better insight ( d = −0.25, p = 0.009), younger age ( d = −0.19, p = 0.003), lower medication usage (Cramer’s V = 0.09, p = 0.017), a negative correlation between symptom severity and illness duration ( r = −0.21, p < 0.001), severe brain dysfunction (Partial η 2 = 0.00–0.01, FDR-corrected p < 0.05), and higher neural vulnerability (positive: 0.25%–4.03%, d = 0.12, FDR-corrected p = 0.177; negative: 0.25%–2.01%, d = 0.31, FDR-corrected p < 0.05). Perceptual dysregulation subtype, defined by negative deviations in the sensorimotor network, visual network, and dorsal attention network ( d = 0.52–1.81, FDR-corrected p < 0.05). This subtype was associated with more severe anxiety/somatization symptoms ( d = −0.15, p = 0.031), older age, higher medication usage, poorer insight, and stable neural vulnerability (positive: 0.14%–2.98%, d = 0.08, FDR-corrected p = 0.333; negative: 0.14%–1.42%, d = −0.24, FDR-corrected p < 0.05). These neuroimaging distinctions corresponded to clinical differences between subtypes, illuminating the heterogeneity of MDD. The findings emphasize the necessity of personalized interventions tailored to the unique neuropathological mechanisms of each subtype, advancing precision medicine in MDD.


  • Top Cited Papers
    Open Access

    HK-ASAP study: protocol for a prospective cohort study on sleep quality, brain reserve and cognitive phenotypes in community-dwelling older adults

    by Xi Ni, Natalie Shu Yang, Yuk Shan Yuen, Yuqi Gong, Zeyan Li, Xiaoqing Hu, Yixuan Yuan, Hanna Lu

    Background: The changes of circadian rhythm are very common in older adults, which can lead to decreased quality of life and jeopardize the brain health in the long run. Among all the types of sleep disturbances, poor sleep quality, as a modifiable condition, can greatly affect the daily activities, cognitive functions, quality of life, and even be implicated as a key potential contributing factor in the development of accelerated cognitive decline and prodromal dementia. Consequently, research efforts to understand, and thus potentially model, the effects of sleep quality on cognition and brain during ageing are of great pragmatic values. Methods: The Hong Kong Cohort of Abnormal Sleep in Ageing Population (HK-ASAP) project is a prospective cohort study recruiting 244 older adults with sleep disturbances. The HK-ASAP study plans to measure sleep quality, brain reserve and cognition at baseline and 2 years. Subjective sleep quality will be assessed by the Pittsburgh Sleep Quality Index (PSQI). Global cognition and domain-specific cognitive functions will be assessed by a comprehensive neuropsychological battery. High-resolution structural magnetic resonance imaging (MRI) data will be acquired and used to quantify the brain reserve, including gray matter volume, cortical thickness and brain age matrices. Saliva samples will be collected for measuring the levels of A β 40 and A β 42, and A β 42/40 ratio. Using the data, we will estimate and compare the sleep quality and its associations with cognition, salivary A β , and brain reserve in older adults. Discussion: The bidirectional relationship between subjective sleep quality and cognitive functions in older adults presents an urgent need to elucidate how poor sleep quality affects cognition and its potential interplay with brain reserve and neuropathological factors. The HK-ASAP study will be a valuable resource for both epidemiological and clinical research, as it will provide fundamental information to identify the individuals at risk of developing cognitive decline. Findings from the HK-ASAP study will inform the development of targeted interventions to enhance sleep quality, cognition, and healthy longevity in older adults. Trial registration: ClinicalTrials.gov Identifier: NCT06170073 (registered on 01/10/2023).


  • Open Access

    White Matter Abnormalities in Bipolar II and Unipolar Depression – Evidence from Fixel-Based Analysis

    by Idy W. Y. Chou, Anna Manelis, Holly A. Swartz, Owen N. W. Leung, Mary L. Phillips, Suzanne H. W. So, Winnie C. W. Chu, Hanna Lu, Linda C. W. Lam, Arthur D. P. Mak

    Background: Challenges in correctly identifying bipolar II disorder (BD-II) during depressive states have led to poor clinical outcomes. BD-II-specific imaging investigations are lacking. This study addresses current knowledge gaps by comparing white matter (WM) integrity in BD-II and unipolar depression (UD) using fixel-based analysis. Method: Fibre density (FD), fibre cross-section (FC), and the combined measure (FDC) within 72 WM tracts were compared among 33 individuals with BD-II, 50 with UD, and 51 healthy controls (HC). The effects of illness characteristics on FBA correlates were also examined. Sensitivity analyses compared these measures among unmedicated participants to check whether medication status affects the results. Results: Participants with BD-II and UD showed reduced FD in the left parieto-occipito-pontine (POPT) and striato-occipital (ST-OCC) tracts. Compared to UD, BD-II was associated with lower FD in the left arcuate fascicle (AF) and bilateral superior longitudinal fasciculi I and II (SLF-I and II). In BD-II, illness duration negatively correlated with FD in left AF, left POPT, and right ST-OCC, while the number of lifetime BD-II depressive episodes positively correlated with FDC in left SLF-I. Group differences were significant but less pronounced in unmedicated participants. Conclusions: Our findings demonstrate shared and distinct WM abnormalities in tracts involved in visuomotor and executive processes in BD-II and UD, with BD-II exhibiting more extensive alterations. With BD-II, but not UD, longer illness duration was linked to lower FD, while depression recurrence was associated with higher FDC, suggesting potential degenerative and compensatory neurobiological mechanisms. Longitudinal studies should investigate the joint trajectories of symptomatology and WM alterations.

  • Open Access

    Targeting the Hippocampal CA1 in Older Adults: A Simulation Study of Low‐Intensity Transcranial Ultrasound Stimulation

    by Kaipeng Wang, Yuke Luo, Zeyan Li, Liwei Guo, Lin Meng, Yi Yuan, Yan Shao, Hanna Lu

    Background: Low‐intensity transcranial ultrasound stimulation (TUS) is an advanced noninvasive neuromodulation technique with great clinical potential. The hippocampal cornu ammonis 1 (CA1) is a crucial subfield for higher cognitive functions, such as memory formation, and is integrally involved in sleep‐dependent memory consolidation. Objectives: This study sought to establish computational models for low‐intensity TUS targeting the bilateral CA1 and to analyze the simulation parameters. Methods: We recruited eight young adults (mean age: 25.75 years) and 10 cognitively unimpaired older adults (mean age: 68.98 years). Based on T1‐weighted magnetic resonance imaging (MRI) data, bilateral CA1 volumes were segmented and quantified for target localization. We constructed a simulation model on the k‐Plan platform for low‐intensity TUS delivered to the bilateral CA1 through the lateral pathway. Hemispheric‐specific focal distance, spatial‐peak pulse‐average intensity (ISPPA), maximum temperature change ( Δ T ), and mechanical index (MI) were compared between age groups. Results: Compared with young adults, older adults showed significantly shorter focal distance ( t = 3.61, p = 0.003), higher in situ ISPPA ( t = −4.38, p = 0.001), higher maximum Δ T ( t = −6.50, p < 0.001), and higher MI ( t = −3.40, p = 0.008) induced by low‐intensity TUS targeting right CA1. A significant hemispheric difference in focal distance was observed exclusively in older adults, with the left CA1 exhibiting a longer focal distance than the right side ( t = 2.34, p = 0.044). Correlation analyses incorporating volumetric data further revealed different age‐related patterns across two age groups. Conclusion: This study evaluates the age‐ and hemisphere‐related differences in low‐intensity TUS simulations targeting the bilateral CA1 in young and older adults. These findings provide important guidance for the clinical translation of low‐intensity TUS in the aging population and the development of personalized therapeutic protocols.

  • Transcriptional Signatures of Mitochondrial Metabolism Predict Esketamine-Induced rACC Structural Changes in Adolescent Major Depression

    by Yanling Zhou, Weicheng Li, Xiaofeng Lan, Chengyu Wang, Xiaoyu Chen, Zhanjie Luo, Fan Zhang, Guanxi Liu, Zitao Wu, Junhao Shen, et al.